Preclinical Activity of SAR408701: A Novel Anti-CEACAM5–maytansinoid Antibody–drug Conjugate for the Treatment of CEACAM5-positive Epithelial Tumors

Stéphanie Decary(Sanofi (France)), Véronique Blanc(Sanofi (France))
Clinical Cancer Research
October 12, 2020
Cited by 79


Related Papers

No related papers found

Powered by citation graph analysis